922P

Trilogy^® Pretreatment Solution

• UNSPSCコード: 12352203
• NACRES: NA.47

特性

• 詳細: For In Vitro Diagnostic Use in Select Regions
• 品質水準: 100; 500
• 形状: aqueous solution
• 包装: pkg of 1 L ready-to-use (922P-09); pkg of 200 mL concentrated 20x (922P-06); pkg of 200 mL ready-to-use (922P-05); pkg of 240 mL concentrated 100x (922P-07); pkg of 50 mL concentrated 20x (922P-04)
• メーカー／製品名: Cell Marque
• テクニック: immunohistochemistry: suitable
• 保管温度: 20-25°C

詳細

詳細

Trilogy^® Pretreatment Solution is intended to be used for immunohistochemical assays on formalin-fixed, paraffin-embedded (FFPE) tissue sections. Using this product eliminates the need for multiple solutions to deparaffinize, rehydrate, and antigen retrieve FFPE tissue samples.¹ The use of a single solution allows for a standardized pretreatment protocol that produces consistent and reliable results when used in conjunction with Cell Marque Primary Antibodies.

1. Aghassi et al. (2003). Composition and Method for Treating Tissue Samples (U.S. Patent No. 6,649,368). U.S. Patent and Trademark Office. https://rb.gy/gy42ef

品質

Note: This product is similar in use to Trilogy^® Pretreatment Solution (920P series products) but does not contain IGEPAL^® CA-630 and complies with European Union (EU) Regulation (EC) No 1907/2006, REACH.

物理的形状

Solution containing pretreatment reagents.

調製ノート

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

その他情報

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

法的情報

IGEPAL is a registered trademark of Solvay

Trilogy is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H315,H317,H412
• 注意書き: P261 - P264 - P272 - P273 - P280 - P302 + P352
• 危険有害性の分類: Aquatic Chronic 3 - Skin Irrit. 2 - Skin Sens. 1
• 保管分類コード: 10 - Combustible liquids
• WGK: WGK 2
• 引火点(°F): >230.0 °F
• 引火点(℃): > 110 °C